Evidence map›Paper›PMID 42245422›Full record

ArticleJournal of surgical case reports2026

Perforated acalculous cholecystitis in a neutropenic patient following chemotherapy: a fatal case report.

Yunpeng Jack Deng

Abstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yunpeng Jack DengGeneral Surgery Department, Eastern Health, 8 Arnold St, Box Hill, Victoria 3128, Australia.ORCID https://orcid.org/0000-0002-0522-4500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acalculous cholecystitis is an uncommon but serious complication of myelosuppressive chemotherapy that is most often observed during profound neutropenia and carries a substantially high morbidity and mortality. This case describes the fulminant course of acalculous cholecystitis in a 78-year-old female receiving carboplatin and vinorelbine for non-small cell lung cancer, with rapid progression from initial presentation to septic shock and multiorgan failure. The case highlights the aggressive nature of acalculous cholecystitis in immunocompromised patients and underscores the importance of early clinical suspicion and prompt intervention in preventing progression to catastrophic outcomes.

Indexed as

acalculous cholecystitiscarboplatinchemotherapy-induced neutropeniagallbladder perforationvinorelbine

Identifiers

PMID42245422
PMCPMC13229914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.